Journal of Clinical Endocrinology & Metabolism, Vol 71, 335-339, Copyright © 1990 by Endocrine Society

ARTICLES

Ketoconazole therapy for women with acne and/or hirsutism

S Venturoli, R Fabbri, L Dal Prato, B Mantovani, M Capelli, O Magrini and C Flamigni
Institute of Reproductive Physiology and Pathology, University of Bologna, Italy.

The effects of ketoconazole, a synthetic imidazole derivate, were evaluated in 42 women affected by acne (17 cases) and/or hirsutism (36 cases) treated with 400 mg/day for 3-6 months. Androstenedione, total and free testosterone, 5 alpha dihydrotestosterone and dehydroepiandrosterone levels progressively dropped during treatment while 17 alpha hydroxyprogesterone, estradiol, ACTH, cortisol, LH and FSH levels increased. Dehydroepiandrosterone sulfate decreased only towards the end of treatment, while estrone, sex hormone binding globulin, and PRL remained unchanged. Daily mean +/- SD rate of hair growth, measured by a special image analysis processor, decreased within 3 months of therapy from 0.258 +/- 0.058 to 0.184 +/- 0.039 mm/day (P less than 0.02) and mean +/- SD hair diameter from 0.123 +/- 0.015 to 0.110 +/- 0.013 mm (P less than 0.05) together with decreasing hormone levels. The therapeutic effects of ketoconazole on hirsutism was evident at 6 months in only 14 subjects, while no significant change in hirsutism score was recorded in 22 women who failed to complete the therapy. Acne improved in all cases. Several side effects and complications arose during treatment, such as headache, nausea, loss of scalp hair, hepatitis, and biochemical changes. Even though ketoconazole improves hyperandrogenism, only selected patients are eligible for treatment as scrupulous monitoring is required.

This article has been cited by other articles:

				D. Deplewski and R. L. Rosenfield Role of Hormones in Pilosebaceous Unit Development Endocr. Rev., August 1, 2000; 21(4): 363 - 392. [Abstract] [Full Text] [PDF]

				E. DIAMANTI-KANDARAKIS and E. ZAPANTI Insulin Sensitizers and Antiandrogens in the Treatment of Polycystic Ovary Syndrome Ann. N.Y. Acad. Sci., April 1, 2000; 900(1): 203 - 212. [Abstract] [Full Text] [PDF]

				S. Venturoli, O. Marescalchi, F. M. Colombo, S. Macrelli, B. Ravaioli, A. Bagnoli, R. Paradisi, and C. Flamigni A Prospective Randomized Trial Comparing Low Dose Flutamide, Finasteride, Ketoconazole, and Cyproterone Acetate-Estrogen Regimens in the Treatment of Hirsutism J. Clin. Endocrinol. Metab., April 1, 1999; 84(4): 1304 - 1310. [Abstract] [Full Text]

				P. S. Kwon, T. Maurer, P. E. LeBoit, R. Aly, and T. G. Berger Hormone-Induced Acneiform Eruption in Human Immunodeficiency Virus Disease Arch Dermatol, March 1, 1998; 134(3): 374 - 376. [Full Text] [PDF]